Notably, this cohort exhibited a more dysfunctional metabolic profile, with prevalence rates of obesity, type 2 diabetes mellitus (T2DM), metabolic syndrome, dyslipidemia, and hypertension of 43%, 25%, 52%, 92%, and 32%, respectively
(PubMed) Boden WE, Probstfield JL, Anderson T, et al
Refills offers a structured, clinician-led approach designed to support safe, ongoing care, all of which is delivered through a cutting-edge digital experience
Retrieved 20 May 2024
Overview of Clinical Studies The efficacy of ZEPBOUND for chronic weight management (weight reduction and maintenance) in conjunction with a reduced-calorie diet and increased physical activity was studied in two randomized, double-blind, placebo-controlled trials (Study 1 and Study 2), in which weight reduction was assessed after 72 weeks of treatment (at least 52 weeks at maintenance dose)
You've truly built up my confidence :) I would love to chat with Dr